Neurocritical Care News

Maintaining a balanced energy intake through diet was associated with significantly better cognitive function compared with uneven intake patterns, researchers reported in Life Metabolism.

Six metabolites — four related to sugar — were consistently associated with lower global cognitive function, researchers reported in Alzheimer’s & Dementia.

The FDA granted accelerated approval to bluebird bio Inc for elivaldogene autotemcel, its gene therapy that aims to slow progression of neurologic dysfunction in boys aged 4 to 17 with early, active cerebral adrenoleukodystrophy, or CALD.

The FDA has accepted a new drug application from Acadia Pharmaceuticals Inc. for trofinetide, a synthetic analog of the amino‐terminal tripeptide of IGF-1 designed to treat core symptoms of Rett syndrome.

Revitalist Lifestyle and Wellness and Wake Network Inc. announced a joint venture to offer ketamine infusions in the U.S. and psilocybin clinical retreats internationally with a special focus on military veterans’ need for access.

The FDA has accepted a new drug application for aripiprazole, a 2-month, ready-to-use, long-acting injectable for the treatment of schizophrenia in adults and maintenance monotherapy treatment of bipolar I disorder in adults.

The daily use of multivitamin-mineral supplements improved global cognition, episodic memory and executive function in older adults, researchers reported in Alzheimer’s & Dementia: The Journal of The Alzheimer’s Association.

Low-dose ketamine was generally safe, well-tolerated and effective in treating clinical symptoms in a small group of children with activity-dependent neuroprotective protein syndrome, researchers reported.

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging have received a $20.5 million grant from the National Institute on Aging to study astrocytes and their role in Alzheimer’s disease and other forms of dementia.

Older adults with dementia are at greater risk for SARS-CoV-2 infection and death, highlighting the need for close monitoring of these patients, researchers reported in the Journal for Alzheimer’s Disease.